STEM CELL CHINA / SHANGRAO

Livingcells,notfrozen.

Advanced cellular therapy under the scientific leadership of academician Han Zhongchao. Treatment of neurodegenerative, cardiovascular, endocrine and autoimmune disorders with freshly isolated stem cells.

By the numbers / 02

  • 500+scientific publications
  • 25technology patents
  • h81academician Han's h-index
  • 15years of expertise since 2007

Why living / 03

Living cells vs frozen

Frozen cells lose 30-40% of their activity upon thawing. Freshly isolated cells retain 100%. This is the scientific cornerstone of our protocol.

Frozen

Frozen

30-40%

Activity lost

Storage in liquid nitrogen, freeze-thaw cycles, cryoprotectants. A portion of the cells dies even before administration.

Living

Living

100%

Activity preserved

Freshly isolated cells are prepared individually for each patient over 6 days. The body receives the most active population possible.

01

100% activity

Freshly isolated cells preserve full therapeutic potential. After thawing, frozen cells lose 30-40% of viability.

02

Fresh, not banked

Cells are prepared individually for each patient over 6 days. No years-long storage in liquid nitrogen.

03

Precise dosing

A known population profile and activity — your physician calculates dosage based on body weight and diagnosis.

04

Safer profile

No cryoprotectants and no freeze-thaw cycle — reducing the immunological burden on the patient.

Recognized by

Hanshi United credentials

Regulators, laboratory accreditations and state awards — all 45 documents are open to verification.

  • PRC Medical Institution Practice License — Hanshi United Hospital (Shangrao)

    PRC Medical License

    PRC Medical Institution Practice License — Hanshi United Hospital (Shangrao)

    2025

  • ISO 9001:2015 — Bureau Veritas (English version)

    ISO 9001:2015

    ISO 9001:2015 — Bureau Veritas (English version)

    2020

  • CNAS L15453 Laboratory Accreditation — Jiangxi

    CNAS · Jiangxi

    CNAS L15453 Laboratory Accreditation — Jiangxi

    2021

  • ANSM (France) Clinical Trial Authorization

    ANSM · France

    ANSM (France) Clinical Trial Authorization

    2019

  • PRC State Science & Technology Progress Award, 1st Class

    PRC State · 1st class

    PRC State Science & Technology Progress Award, 1st Class

    2014

  • European Patent EP 2374871 — Beijing Health & Biotech

    EP 2374871

    European Patent EP 2374871 — Beijing Health & Biotech

    2016

Process / 04

Five steps of your journey

From the first consultation to post-treatment follow-up — we are with you at every stage.

01

Step 1 of 5

Free consultation

We review your medical records and case history. Our academic board evaluates whether cell therapy is the right path for you.

02

Step 2 of 5

Individual treatment plan

We design a personal protocol: cell type, administration route, dosage and number of procedures tailored to your diagnosis.

03

Step 3 of 5

Travel arrangements

We assist with medical visa, flights and accommodation. Free transfer from Sanqingshan Airport.

04

Step 4 of 5

Treatment course

A course of 3 procedures spaced 15–20 days apart. Therapy and rehabilitation at Hanshi United under medical supervision.

05

Step 5 of 5

Post-treatment support

Remote consultations after you return home. The effect unfolds over 3–6 months — we stay with you throughout.

Treatments / 05

Eight directions of cellular therapy

From neurodegenerative diseases to endocrine disorders. About 30 nosologies, with an individual protocol for each diagnosis.

Founder / 06

Academician Han Zhongchao

Member of the French Academy of Medicine and the French Academy of Technologies. H-index 81.

About the academician

Discovered differentiation of hematopoietic stem cells into vascular cells. Developed 8 first-class therapeutics. H-index 81, over 600 publications, 380+ in SCI journals. Listed in Stanford's top-2% scientists worldwide (2022).

  1. Professor at Peking Union Medical College

  2. Laureate of the National Natural Science Foundation of China

  3. Cheung Kong Scholar of the Ministry of Education of China

  4. Director of the National Stem Cell Engineering Research Centre

Stem cells are not a drug. They are a living population that works inside a living body. So the rules must match the living: minimal intervention, maximal control.
韩忠朝 · Han Zhongchao

Video · 4:54

Han's United — who we are

Corporate film about the company: laboratories, clinic, and the 国际细胞谷 research campus.

Han's United — who we are
4:54

Han’s United

Watch the video

Cases / 07

Patient stories

Real clinical cases from the practice of Hanshi United. Names and ages are published with the consent of the families.

4 cases · scroll horizontally

  1. Case · 01 / NY

    China

    Niu Yang(纽阳)

    6 years

    Diagnosis

    Regression starting at 1.5 years: loss of language, cognitive skills, and eye contact

    Course outcome

    Recovery of eye contact, return to communication, progress in cognitive function.

    Day 1Week 3Month 6Year 1
  2. Case · 02 / FL

    China

    Fan Lu(范鲁)

    6 years · 21 кг

    Diagnosis

    Unintelligible speech, EEG abnormalities

    Course outcome

    EEG normalised after the course. Marked speech improvement.

    Day 1Week 3Month 6Year 1
  3. Case · 03 / LC

    China

    Lai Chen(赖晨)

    2 years · 13 кг

    Diagnosis

    Limited speech, weak eye contact, hydrocephalus, nocturnal seizures

    Course outcome

    Reduced seizure frequency, improved motor skills, progress in speech development.

    Day 1Week 3Month 6Year 1
  4. Case · 04 / SW

    China

    Su Wei(苏伟)

    2 years · 14 кг

    Diagnosis

    Functional delays from age 1, unsteady sitting, leukoencephalopathy, epilepsy

    Course outcome

    Epileptic activity stabilised. Improved postural control.

    Day 1Week 3Month 6Year 1

Pause · a moment to ask

Worth starting with a consultation?

No commitment needed. Tell us about the patient — the academic board will give you an honest read on whether cell therapy has a place in your story.

Trust / 08

Recognised internationally

International scientific board

Eight academicians and professors from France and beyond serve on our scientific advisory board.

  • Jacques CAEN

    Jacques CAEN

    French Academy of Medicine, Academy of Technologies, Corresponding Member of the Academy of Sciences

  • Bruno JARRY

    Bruno JARRY

    President of the National Academy of Medicine of France

  • Jean-Pierre CAZENAVE

    Jean-Pierre CAZENAVE

    Member of the French Academy of Medicine

  • Jean-Francois STOLTZ

    Jean-Francois STOLTZ

    Professor of medicine at the University of Lorraine

  • Georges UZAN

    Georges UZAN

    Member of the French Academy of Medicine, director of INSERM U972

  • Jean-Jacques LATAILLADE

    Jean-Jacques LATAILLADE

    Professor, director of the cell therapy centre at Percy Military Hospital (France)

  • Raymond ASTRI

    Raymond ASTRI

    Senior engineer, big-data architecture

  • Constantin AGOURIDAS

    Constantin AGOURIDAS

    Professor at ENSCP, chief expert at IMCELL Lab

Certifications

  • Standard · 01

    CMA

    Accreditation by the China Metrology Administration for laboratory measurements and analysis.

  • Standard · 02

    CNAS

    Accreditation by the China National Accreditation Service for Conformity Assessment — internationally recognised laboratory quality mark.

  • Standard · 03

    ISO 9001

    International quality management system standard for healthcare service organisations.

FAQ / 09

Frequently asked questions

Get started / 10

Start with a free consultation

Tell us about the patient — our academic board will review the case and propose a treatment protocol.

Medical questionnaire · 10–15 min

Speed up your consultation

If you are ready to share the medical history and documents in advance, please fill out the detailed questionnaire. This helps the academic board prepare a personal protocol before the first conversation.

Open questionnaireOpens in a new tab

By submitting this form you agree to our privacy policy

We use cookies and analytics services to improve the website experience. Privacy Policy